Needham & Company Raises Price Target as Impinj (PI) Reports Solid 2Q Report

Go back to Needham & Company Raises Price Target as Impinj (PI) Reports Solid 2Q Report

Impinj (PI) Adds to Strong Post-Earnings Gains

September 2, 2016 11:56 AM EDT

Impinj (NASDAQ: PI) adds to yesterday's strong gains following earnings. Shares are up another 13.7% today on volume that is running 6x the norm. Yesterday the stock was up 21%.

... More

Piper Jaffray Raises price Target on Impinj (PI) to $30 Following June Quarter

September 1, 2016 7:34 AM EDT

Piper Jaffray reiterated an Overweight rating on Impinj Inc (NASDAQ: PI), and raised the price target to $30.00 (from $24.00), following the company's June quarter results. Impinj revenues increased to $26M, which exceeded consensus expectations by $0.7M. Non-GAAP EPS came in $0.04 better than the consensus expectations. September quarter revenues are expected in the range of... More

Impinj (PI): Raising PT After A Beat And Raise Quarter - RBC

September 1, 2016 6:21 AM EDT

RBC Capital analyst, Mitch Steves, maintained his Outperform rating on shares of Impinj Inc (NASDAQ: Pi) and raised the price target to $30.00 (from $25.00) after Impinj reported a beat and raise for its first earnings call. While the software piece of the business is new,... More

After-Hours Stock Movers 08/31: (CYNA) (OXM) (OLLI) Higher; (CRM) (SCVL) (FIVE) Lower (more...)

August 31, 2016 5:46 PM EDT

After-Hours Movers

Cynapsus Therapeutics Inc. (NASDAQ: CYNA) 119% HIGHER; Sunovion Pharmaceuticals Inc. and Cynapsus Therapeutics Inc. (NASDAQ: CYNA) announced that the companies have signed a definitive agreement under which Sunovion will acquire Cynapsus for US$40.50 per share in cash. The transaction has received unanimous approval by the Board of Directors of both companies and values Cynapsus at approximately US$624 million (or approximately CAN$820 million). The acquisition will be funded with cash on hand. The transaction is expected to close in the fourth quarter of 2016... More

Impinj (PI) Tops Q2 EPS by 4c; Offers Q3 Outlook

August 31, 2016 4:04 PM EDT

Impinj (NASDAQ: PI) reported Q2 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $26 million versus the consensus estimate of $25.31 million.

GUIDANCE:

Impinj sees Q3 2016 EPS of $0.01-$0.09, versus the consensus of $0.04. Impinj sees Q3... More